Natural Weight Loss Program, Better Than Drugs
According to studies on file at the NAAFA office, the risks of these three drugs include primary pulmonary hypertension, valvular heart disease, and neurotoxicity. Under fire from NAAFA and other consumer advocates and following studies which indicated that one-third of users of dexfenfluramine and fenfluramine had contracted valvular heart disease, the FDA strongly recommended halting the sale of these drugs, and drug companies withdrew dexfenfluramine and fenfluramine from the U.S. Instead the FDA recommended a natural weight loss that includes sensible eating and exercise.